Evaluation of Nafamostat as Chemoprophylaxis for SARS-CoV-2 Infection in Hamsters
The successful development of a chemoprophylaxis against SARS-CoV-2 could provide a tool for infection prevention that is implementable alongside vaccination programmes. Nafamostat is a serine protease inhibitor that inhibits SARS-CoV-2 entry in vitro, but it has not been characterised for chemoprop...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| 格式: | 文件 |
| 语言: | English |
| 出版: |
MDPI AG
2023-08-01
|
| 丛编: | Viruses |
| 主题: | |
| 在线阅读: | https://www.mdpi.com/1999-4915/15/8/1744 |